Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/VIA stock hub

FRA/VIA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/VIAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/VIA

In the news

Latest news · FRA/VIA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E6.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-2

P25 n/aP50 n/aP75 n/a

ROIC5.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/VIA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	30,000
Employees Change	-2,000%
Employees Change Percent	-6.25
Enterprise value	EUR 27.4B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 17B
Price	EUR 14.81
Price currency	EUR
Rev Per Employee	421,004.77x
Sic	2834
Symbol	fra/VIA
Website	https://www.viatris.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.51%
EV Earnings	-106.4x
EV/EBIT	23.18x
EV/EBITDA	7.64x
EV/FCF	17.6x
EV/Sales	2.21x
FCF yield	9.15%
Forward P/E	6.81x
P/B ratio	1.34x
P/S ratio	1.35x
PE Ratio10 Y	82.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.54%
EBITDA Margin	28.33%
FCF margin	12.31%
Gross margin	39.82%
Gross Profit	EUR 5B
Gross Profit Growth	-0.43%
Gross Profit Growth Q	11.58%
Gross Profit Growth3 Y	-5.15%
Gross Profit Growth5 Y	1.41%
Net Income	EUR -257.2M
Pretax Margin	-5.6%
Profit Margin	-2.04%
Profit Per Employee	EUR -8,572
ROA	2.31
Roa5y	2.25
ROCE	4.63
ROE	-1.96
Roe5y	-3.98
ROIC	5.07
Roic5y	3.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	107.23%
Cagr3y	27.09%
Cagr5y	9.73%
Div CAGR3	-3.52%
FCF Growth	-5.9%
FCF Growth Q	-29.32%
FCF Growth3 Y	-9.22%
FCF Growth5 Y	3.08%
OCF Growth	-2.48%
OCF Growth Q	-27.49%
OCF Growth10 Y	1.76%
OCF Growth3 Y	-8%
OCF Growth5 Y	3.92%
Revenue Growth	1.62x
Revenue Growth Q	8.07x
Revenue Growth3 Y	-2.68x
Revenue Growth5 Y	1.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.39
Assets	EUR 31.9B
Cash	EUR 2.1B
Current Assets	EUR 9.3B
Current Liabilities	EUR 5.8B
Debt	EUR 12.7B
Debt EBITDA	EUR 3.46
Debt Equity	EUR 1
Debt FCF	EUR 8.15
Equity	EUR 12.7B
Interest Coverage	2.92
Liabilities	EUR 19.2B
Long Term Assets	EUR 22.7B
Long Term Liabilities	EUR 13.5B
Net Cash	EUR -10.6B
Net Cash By Market Cap	EUR -62.34
Net Debt EBITDA	EUR 2.96
Net Debt Equity	EUR 0.83
Net Debt FCF	EUR 6.81
Tangible Book Value	EUR -5.7B
Tangible Book Value Per Share	EUR -4.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.6
Inventory Turnover	2.18
Net Working Capital	EUR 3.2B
Quick ratio	0.9
Working Capital	EUR 3.6B
Working Capital Turnover	EUR 3.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.61%
Dividend Growth	-5.91%
Dividend Growth Years	0%
Dividend per share	EUR 0.42
Dividend Years	6
Dividend Yield	2.82%
Ex Div Date	2026-03-09
Last Dividend	EUR 0.1
Payout Frequency	Quarterly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	107.12%
200-day SMA	10.27
3Y total return	105.3%
50-day SMA	12.27
50-day SMA vs 200-day SMA	50over200
5Y total return	59.07%
All Time High	15.4
All Time High Change	-3.83%
All Time High Date	2021-01-08
All Time Low	6.26
All Time Low Change	136.51%
All Time Low Date	2025-04-10
ATR	0.36
Ch YTD	42.34
High	14.81
High52	14.81
High52 Date	2026-05-08
High52ch	0%
Low	14.55
Low52	7.29
Low52 Date	2025-05-27
Low52ch	103.27%
Ma50ch	20.7%
Price vs 200-day SMA	44.21%
RSI	80.33
RSI Monthly	67.7
RSI Weekly	75.89
Sharpe ratio	2.03x
Sortino ratio	3.92
Total Return	5.43%
Tr YTD	43.54
Tr1m	29.35%
Tr1w	14.54%
Tr3m	22.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.2B
Operating Income Growth	10.41
Operating Income Growth Q	187.5
Operating Income Growth3 Y	-17.95
Operating Income Growth5 Y	3.78
Operating margin	9.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,154,493,916%
Net Borrowing	-1,102,350.6
Shares Insiders	0.7%
Shares Institutions	86.04%
Shares Qo Q	1.97%
Shares Yo Y	-2.61%
Short Ratio	3.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.4B
Average Volume	249.4x
Bv Per Share	10.92
CAPEX	EUR -326.2M
Ch1m	29.35
Ch1w	14.54
Ch1y	97.84
Ch3m	21.49
Ch3y	79.32
Ch5y	28.9
Ch6m	70.86
Change	3.48%
Change From Open	1.52
Close	14.31
Days Gap	1.93
Depreciation Amortization	2,319,854,439.6
Dollar Volume	16,602
Earnings Date	2026-05-07
EBIT	EUR 1.2B
EBITDA	EUR 3.6B
EPS	EUR -0.22
F Score	5
FCF	EUR 1.6B
FCF EV Yield	5.68x
Financing CF	-893,926,110
Fiscal Year End	December
Founded	1,961
Goodwill	5,674,900,888.8
Income Tax	EUR -450M
Investing CF	-73,893,960
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	10.87
Ma150ch	36.2%
Ma20	12.61
Ma20ch	17.47%
Net CF	910,144,620
Next Earnings Date	2026-08-07
Open	14.59
P FCF Ratio	10.93
P OCF Ratio	9.03
Payment Date	2026-03-18
Position In Range	100
Ppne	2,358,097,525.8
Price Date	2026-05-08
Price EBITDA	EUR 4.75
Relative Volume	4.49x
Revenue	12,630,142,980x
SBC By Revenue	1.17x
Share Based Comp	148,048,110
Tax By Revenue	-3.56x
Tr6m	74.3%
Volume	1,121
Z Score	0.98

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/VIA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.8%

$0.42 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+5.4%

Next ex-dividend date: 2026-03-09

Performance

FRA/VIA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/VIA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.0%

Share of float held by funds and institutions

Insider ownership

+0.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/VIA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

80.3

Above 70: short-term overbought

Price vs 200-day MA

+44.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/VIA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/VIA stock rating?

fra/VIA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/VIA analysis?

The full report lives at /stocks/fra/VIA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/VIA?

The latest report frames fra/VIA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/VIA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.